z-logo
Premium
Do sulfonylureas still have a role in type 2 diabetes?
Author(s) -
Krentz Andrew,
Sinclair Alan
Publication year - 2011
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.759
Subject(s) - medicine , type 2 diabetes , sulfonyl , intensive care medicine , diabetes mellitus , interface (matter) , pharmacology , endocrinology , biochemistry , pulmonary surfactant , alkyl , chemistry , gibbs isotherm , organic chemistry
The prescribing of sulfonylureas has declined in recent years with the introduction of newer agents in the treatment of type 2 diabetes. The authors argue, however, that the judicial use of a sulfonyl ‐ urea can still be both effective and well tolerated. Copyright © 2011 Wiley Interface Ltd

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here